ibuprofen has been researched along with Multiple Sclerosis, Relapsing-Remitting in 4 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Multiple Sclerosis, Relapsing-Remitting: The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Naproxen and ibuprofen were more effective than acetaminophen in minimizing physical side effects of IFN beta-1a." | 6.71 | A randomized open label study of pain medications (naproxen, acetaminophen and ibuprofen) for controlling side effects during initiation of IFN beta-1a therapy and during its ongoing use for relapsing-remitting multiple sclerosis. ( Filipi, M; Healey, K; Leuschen, MP, 2004) |
| "Naproxen and ibuprofen were more effective than acetaminophen in minimizing physical side effects of IFN beta-1a." | 2.71 | A randomized open label study of pain medications (naproxen, acetaminophen and ibuprofen) for controlling side effects during initiation of IFN beta-1a therapy and during its ongoing use for relapsing-remitting multiple sclerosis. ( Filipi, M; Healey, K; Leuschen, MP, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Río, J | 1 |
| Nos, C | 1 |
| Bonaventura, I | 1 |
| Arroyo, R | 1 |
| Genis, D | 1 |
| Sureda, B | 1 |
| Ara, JR | 1 |
| Brieva, L | 1 |
| Martín, J | 1 |
| Saiz, A | 1 |
| Sánchez López, F | 1 |
| Prieto, JM | 1 |
| Roquer, J | 1 |
| Dorado, JF | 1 |
| Montalban, X | 1 |
| Leuschen, MP | 1 |
| Filipi, M | 1 |
| Healey, K | 1 |
| Brandes, DW | 1 |
| Bigley, K | 1 |
| Hornstein, W | 1 |
| Cohen, H | 1 |
| Au, W | 1 |
| Shubin, R | 1 |
| Reess, J | 1 |
| Haas, J | 1 |
| Gabriel, K | 1 |
| Fuhlrott, A | 1 |
| Fiola, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Trial of Prednisone and Acetaminophen Versus Acetaminophen Alone in Minimizing Flu-like Symptoms From Pegylated Interferon Beta-1a[NCT03424733] | Phase 4 | 50 participants (Anticipated) | Interventional | 2017-09-25 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for ibuprofen and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: a randomized trial.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Asthenia; Chills; Double-Blind Method; Drug Administ | 2004 |
A randomized open label study of pain medications (naproxen, acetaminophen and ibuprofen) for controlling side effects during initiation of IFN beta-1a therapy and during its ongoing use for relapsing-remitting multiple sclerosis.
Topics: Acetaminophen; Adjuvants, Immunologic; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, No | 2004 |
Alleviating flu-like symptoms with dose titration and analgesics in MS patients on intramuscular interferon beta-1a therapy: a pilot study.
Topics: Acetaminophen; Adjuvants, Immunologic; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Drug Thera | 2007 |
Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-1a (AVONEX) therapy.
Topics: Acetaminophen; Adult; Chills; Female; Fever; Headache; Humans; Ibuprofen; Interferon beta-1a; Interf | 2002 |